There is increasing evidence that the expression levels of ERRα are higher in human breast tumors when compared to normal breast tissue [23], and that ERRα overexpression is associated with adverse clinical outcome and recurrence in breast cancer patients [52,56,57]. This evidence concerns the gene ESRRA and breast carcinoma.